Multiplexed detection of antibodies using programmable bead arrays.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

The detection of antibodies in sera has broad applications for detection and monitoring of infectious diseases, autoimmunity, and cancer. Proteomic methods of antigen detection, such as protein microarrays, are excellent clinical discovery tools, but due to both cost and specialization of manufacture, these are limited to screening small numbers of sera. Downstream assays for biomarker validation studies require rapid, reproducible, multiplexed assays for the simultaneous screening of fewer (<100) antigens with hundreds or thousands of sera. Traditional clinical ELISA assays use recombinant proteins, but these are limited by the ability to purify proteins free of cross-reacting contaminants and are limited to one antigen at a time. Here, we describe the application of coupled in vitro protein production with anti-tag capture onto bead arrays, for the rapid multiplexed detection of antibodies in sera. These assays can be readily adapted for detection of any protein-specific infectious, autoimmune, or cancer-specific antibodies.

Original languageEnglish (US)
Pages (from-to)227-238
Number of pages12
JournalMethods in molecular biology (Clifton, N.J.)
Volume723
DOIs
StatePublished - 2011
Externally publishedYes

Fingerprint

Antibodies
Serum
Antigens
Protein Array Analysis
Proteins
Validation Studies
Autoimmunity
Recombinant Proteins
Proteomics
Communicable Diseases
Neoplasms
Biomarkers
Enzyme-Linked Immunosorbent Assay
Costs and Cost Analysis
In Vitro Techniques

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Multiplexed detection of antibodies using programmable bead arrays. / Anderson, Karen.

In: Methods in molecular biology (Clifton, N.J.), Vol. 723, 2011, p. 227-238.

Research output: Contribution to journalArticle

@article{4c847af055774450a24c182115a89b9c,
title = "Multiplexed detection of antibodies using programmable bead arrays.",
abstract = "The detection of antibodies in sera has broad applications for detection and monitoring of infectious diseases, autoimmunity, and cancer. Proteomic methods of antigen detection, such as protein microarrays, are excellent clinical discovery tools, but due to both cost and specialization of manufacture, these are limited to screening small numbers of sera. Downstream assays for biomarker validation studies require rapid, reproducible, multiplexed assays for the simultaneous screening of fewer (<100) antigens with hundreds or thousands of sera. Traditional clinical ELISA assays use recombinant proteins, but these are limited by the ability to purify proteins free of cross-reacting contaminants and are limited to one antigen at a time. Here, we describe the application of coupled in vitro protein production with anti-tag capture onto bead arrays, for the rapid multiplexed detection of antibodies in sera. These assays can be readily adapted for detection of any protein-specific infectious, autoimmune, or cancer-specific antibodies.",
author = "Karen Anderson",
year = "2011",
doi = "10.1007/978-1-61779-043-0_15",
language = "English (US)",
volume = "723",
pages = "227--238",
journal = "Methods in molecular biology (Clifton, N.J.)",
issn = "1064-3745",
publisher = "Humana Press",

}

TY - JOUR

T1 - Multiplexed detection of antibodies using programmable bead arrays.

AU - Anderson, Karen

PY - 2011

Y1 - 2011

N2 - The detection of antibodies in sera has broad applications for detection and monitoring of infectious diseases, autoimmunity, and cancer. Proteomic methods of antigen detection, such as protein microarrays, are excellent clinical discovery tools, but due to both cost and specialization of manufacture, these are limited to screening small numbers of sera. Downstream assays for biomarker validation studies require rapid, reproducible, multiplexed assays for the simultaneous screening of fewer (<100) antigens with hundreds or thousands of sera. Traditional clinical ELISA assays use recombinant proteins, but these are limited by the ability to purify proteins free of cross-reacting contaminants and are limited to one antigen at a time. Here, we describe the application of coupled in vitro protein production with anti-tag capture onto bead arrays, for the rapid multiplexed detection of antibodies in sera. These assays can be readily adapted for detection of any protein-specific infectious, autoimmune, or cancer-specific antibodies.

AB - The detection of antibodies in sera has broad applications for detection and monitoring of infectious diseases, autoimmunity, and cancer. Proteomic methods of antigen detection, such as protein microarrays, are excellent clinical discovery tools, but due to both cost and specialization of manufacture, these are limited to screening small numbers of sera. Downstream assays for biomarker validation studies require rapid, reproducible, multiplexed assays for the simultaneous screening of fewer (<100) antigens with hundreds or thousands of sera. Traditional clinical ELISA assays use recombinant proteins, but these are limited by the ability to purify proteins free of cross-reacting contaminants and are limited to one antigen at a time. Here, we describe the application of coupled in vitro protein production with anti-tag capture onto bead arrays, for the rapid multiplexed detection of antibodies in sera. These assays can be readily adapted for detection of any protein-specific infectious, autoimmune, or cancer-specific antibodies.

UR - http://www.scopus.com/inward/record.url?scp=79958269748&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79958269748&partnerID=8YFLogxK

U2 - 10.1007/978-1-61779-043-0_15

DO - 10.1007/978-1-61779-043-0_15

M3 - Article

VL - 723

SP - 227

EP - 238

JO - Methods in molecular biology (Clifton, N.J.)

JF - Methods in molecular biology (Clifton, N.J.)

SN - 1064-3745

ER -